HomeNews & MediaPress ReleasesPhilogen receives authorisation to initiate new study in France to evaluate Nidlegy™ in several non-melanoma skin cancersPress ReleasePublishedFebruary 17, 2022Philogen receives authorisation to initiate new study in France to evaluate Nidlegy™ in several non-melanoma skin cancersMore details
